Cyclosporine — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Psoriasis

• Apremilast
• Betamethasone dipropionate
• Calcipotriene
• Methotrexate

Other medications in Dermatology

• Dapsone Topical
• Desonide
• Doxycycline
• Fluocinonide
• Fluorouracil Cream
• Fluorouracil Topical
• Hydrocortisone
• Hydrocortisone Topical

About Cyclosporine

Cyclosporine is a crucial medication that plays a vital role in preventing organ transplant rejection and managing severe autoimmune diseases. Its ability to modulate the immune system makes it indispensable for many. At TheDrugClub, we believe access to such life-saving treatments shouldn't be a financial burden. Discover how our membership can bring you significant savings on cyclosporine. ## Cyclosporine: A Pillar of Immunosuppression

Cyclosporine is a powerful immunosuppressant medication that has revolutionized the treatment of various conditions where the body's immune system needs to be carefully managed. It's most widely known for its critical role in preventing organ transplant rejection, ensuring that recipients of kidney, liver, heart, and lung transplants can live healthier, longer lives with their new organs. Without it, the body's immune system would recognize the transplanted organ as foreign and launch an attack. Beyond transplantation, cyclosporine is also a key treatment for several severe autoimmune diseases. These include conditions where the immune system mistakenly attacks healthy tissues, such as severe rheumatoid arthritis, chronic severe psoriasis, severe atopic dermatitis (eczema), and certain forms of nephrotic syndrome. It can also be used in conditions like aplastic anemia, where the bone marrow fails to produce enough blood cells. ### How This Vital Medication Works

At its core, cyclosporine works by selectively suppressing the activity of specific immune cells, primarily T-lymphocytes (T-cells). These T-cells are central to the body's immune response, responsible for identifying and attacking foreign invaders or, in the case of autoimmune diseases, healthy tissues. Cyclosporine achieves this by inhibiting an enzyme called calcineurin, which is crucial for activating T-cells. By blocking calcineurin, cyclosporine effectively reduces the production of cytokines—signaling molecules that promote inflammation and immune responses. This targeted action helps to dampen the immune system's overactivity, preventing it from damaging transplanted organs or self-tissues, while ideally leaving other parts of the immune system somewhat intact to fight off infections. Due to its potent effects, cyclosporine treatment requires careful monitoring by a healthcare professional. ### The Cost of Cyclosporine: A Significant Barrier for Many

For many, the cost of cyclosporine can be a substantial financial burden. Depending on the specific formulation (e.g., modified vs. non-modified), dosage, and whether it's a brand-name drug (like Sandimmune, Neoral, or Gengraf) or a generic equivalent, monthly costs can range from hundreds to even thousands of dollars without adequate insurance coverage or with high deductibles. This high price tag can create immense stress for patients who rely on this medication for their health and well-being, making consistent access a serious challenge. As a member, you simply pay your monthly membership fee, and we cover the cost of your cyclosporine prescription

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Cyclosporine is approved for (FDA label)

Kidney, Liver, and Heart Transplantation Cyclosporine capsules (modified) is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Cyclosporine capsules (modified) has been used in combination with azathioprine and corticosteroids. Rheumatoid Arthritis Cyclosporine capsules (modified) is indicated for the treatment of patients with severe active, rheumatoid arthritis where the disease has not adequately responded to methotrexate. Cyclosporine capsules (modified) can be used in combination with methotrexate in rheumatoid arthritis patients who do not respond adequately to methotrexate alone.

Source: Read the full FDA label on DailyMed. Label effective date: September 10, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Cyclosporine (FDA label)

WARNING Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe cyclosporine capsules (modified). At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe cyclosporine capsules (modified). Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient. Cyclosporine capsules (modified), a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients cyclosporine capsules (modified) may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients. Cyclosporine capsules (modified) have increased bioavailability in comparison to Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) [NON-MODIFIED]. Cyclosporine capsules (modified) and Sandimmune ® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with cyclosporine capsules (modified) than with Sandimmune ® . If a patient who is receiving exceptionally high doses of Sandimmune ® is converted to cyclosporine capsules (modified), particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking cyclosporine capsules (modified) to avoid toxicity due to high concentrations.

Source: FDA prescribing information (DailyMed). Set ID: 5baaf78c-90f6-abcf-52c8-814490f3cf9f. SPL document ID: deb75383-63a0-8509-1aee-0702c085a05e. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Cyclosporine (FDA label)

Kidney, Liver, and Heart Transplantation The principal adverse reactions of cyclosporine therapy are renal dysfunction, tremor, hirsutism, hypertension, and gum hyperplasia. Hypertension Hypertension, which is usually mild to moderate, may occur in approximately 50% of patients following renal transplantation and in most cardiac transplant patients. Glomerular Capillary Thrombosis Glomerular capillary thrombosis has been found in patients treated with cyclosporine and may progress to graft failure. The pathologic changes resembled those seen in the hemolytic-uremic syndrome and included thrombosis of the renal microvasculature, with platelet-fibrin thrombi occluding glomerular capillaries and afferent arterioles, microangiopathic hemolytic anemia, thrombocytopenia, and decreased renal function. Similar findings have been observed when other immunosuppressives have been employed post-transplantation.

Source: FDA prescribing information (DailyMed). Set ID: 5baaf78c-90f6-abcf-52c8-814490f3cf9f. SPL document ID: deb75383-63a0-8509-1aee-0702c085a05e. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Cyclosporine (FDA label)

General Cyclosporine capsules (modified) is contraindicated in patients with a hypersensitivity to cyclosporine or to any of the ingredients of the formulation. Rheumatoid Arthritis Rheumatoid arthritis patients with abnormal renal function, uncontrolled hypertension, or malignancies should not receive cyclosporine capsules (modified). Psoriasis Psoriasis patients who are treated with cyclosporine capsules (modified) should not receive concomitant PUVA or UVB therapy, methotrexate or other immunosuppressive agents, coal tar or radiation therapy. Psoriasis patients with abnormal renal function, uncontrolled hypertension, or malignancies should not receive cyclosporine capsules (modified).

Source: FDA prescribing information (DailyMed). Set ID: 5baaf78c-90f6-abcf-52c8-814490f3cf9f. SPL document ID: deb75383-63a0-8509-1aee-0702c085a05e. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Cyclosporine (FDA label)

A. Effect of Drugs and Other Agents on Cyclosporine Pharmacokinetics and/or Safety All of the individual drugs cited below are well substantiated to interact with cyclosporine. In addition, concomitant use of NSAIDs with cyclosporine, particularly in the setting of dehydration, may potentiate renal dysfunction. Caution should be exercised when using other drugs which are known to impair renal function ( see WARNINGS , Nephrotoxicity ). Drugs That May Potentiate Renal Dysfunction Antibiotics Antineoplastic s Antifungals Anti- Inflammatory Drugs Gastrointestinal Agents Immunosuppressives Other Drugs ciprofloxacin gentamicin tobramycin vancomycin trimethoprim with sulfamethoxazole melphalan amphotericin B ketoconazole azapropazon colchicine diclofenac naproxen sulindac cimetidine ranitidine tacrolimus fibric acid derivatives (e.g., bezafibrate, fenofibrate) methotrexate During the concomitant use of a drug that may exhibit additive or synergistic renal impairment with cyclosporine, close monitoring of renal function (in particular serum creatinine) should be performed.

Source: FDA prescribing information (DailyMed). Set ID: 5baaf78c-90f6-abcf-52c8-814490f3cf9f. SPL document ID: deb75383-63a0-8509-1aee-0702c085a05e. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.